
Roche is looking to its innovative late-stage pipeline to help it get back on track for the next financial year …

A promising Roche drug has helped previously untreated patients with advanced skin cancer to live longer without their disease getting …
Roche’s mid-stage melanoma candidate has produced positive results in a difficult to treat cancer. RG7204 is an investigational, first-in-class molecule …
Jennings becomes President of Beckman Coulter Diagnostics
Boyds expands Regulatory Affairs team to support growing demand
Sterling doubles ADC manufacturing capacity at Welsh facility
Femtosecond laser cuts lung tumour margin assessment time

